Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
3(30%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_3
1
10%
Ph not_applicable
6
60%
Ph phase_1
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(5)
Other(2)

Detailed Status

Completed5
Recruiting2
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (12.5%)
Phase 31 (12.5%)
N/A6 (75.0%)

Trials by Status

recruiting220%
active_not_recruiting110%
unknown220%
completed550%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
OTHER
Total Trials
10